Drug Index



Mechanism :

It is an anthracycline. Replication is decreased by binding to DNA topoisomerase II and seems to inhibit the incorporation of uridine into RNA and thymidine into DNA.

Indication :

• Initial treatment of acute non-lymphocytic leukemia

• Secondary progressive or relapsing-remitting multiple sclerosis (MS)


• Acute lymphocytic leukemia (ALL)

• Autologous hematopoietic stem cell transplantation (HSCT) (conditioning regimen)

• Breast cancer (metastatic)

• Hodgkin lymphoma (refractory)

• Non-Hodgkin lymphomas (NHL)

• Pediatric acute myelogenous leukemia (AML)

• Pediatric acute promyelocytic leukemia (APL)

• Relapsed acute myeloid leukemia (AML)

Contraindications :

Hypersensitivity to mitoxantrone or any component of the formulation.

Dosing :

Acute myeloid leukemia (AML) consolidation phase (second course), acute promyelocytic leukemia (APL) consolidation phase (second course):

10 mg/sqm IV once daily for 5 days.

Adverse Effect :

Nausea, alopecia, UTI, amenorrhea, diarrhea, stomatitis, constipation, headache, back pain, cardiotoxicity, myelosuppression, decreased left ventricular ejection fraction, hepatotoxicity, and abnormal transaminases.

Interaction :

Clozapine: Myelosuppressive Agents may enhance the adverse/toxic effect of Clozapine.
Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide.
Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of live vaccines.

03/11/2020 23:15:22 Mitoxantrone
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0